The Changing Environment Around Accelerated Approvals and Regulatory Pathways
PharmaTalkRadio7 Okt 2022

The Changing Environment Around Accelerated Approvals and Regulatory Pathways

In this session recorded at CMO Summit 2022, panelists share strategy trends and opportunities around accelerated approvals and regulatory designations. Additionally, they discuss: How to approach the FDA based on the different types of meetingsHow these trends and pathways affect trial designImplications after approval based on the pathway Speakers: Edith Perez, MD, CMO, Bolt BiotherapeuticsJeffrey Bornstein, MD, CMO, Eledon PharmaceuticalsAmy Blawas, PhD, Principal Consultant, NDA Group

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(461)

Populärt inom Vetenskap

dumma-manniskor
p3-dystopia
allt-du-velat-veta
hacka-livet
rss-vetenskapsradion
ufo-sverige
svd-nyhetsartiklar
bildningspodden
rss-vetenskapsradion-2
barnpsykologerna
rss-spraket
det-morka-psyket
halsorevolutionen
vetenskapsradion
medicinvetarna
ufo-sverige-2
rss-ufobortom-rimligt-tvivel
paranormalt-med-caroline-giertz
sexet
rss-kriminologerna